Fundraising Fox

Rejuvenate Bio

San Diego, US · Delaware corporation · 4 known investors

rejuvenatebio.com ↗

Rejuvenate Bio develops gene therapy treatments targeting the root causes of aging to address chronic diseases such as osteoarthritis, heart disease, and cancer in companion animals and humans.

BiotechHealthtechLongevity@rejuvenatebio

Founders & leadership

ND
Noah DavidsohnExecutive Officer, Director
DO
Daniel OliverExecutive Officer, Director
DZ
David ZhuDirector

Investors · 4

Companion FundNew York
Connecticut InnovationsNew Haven · $500K – $2M
Kendall Capital PartnersBoston
KdT Venturesreported · 2 sourcesAustin · $500K – $3M

Reported raises · per SEC filings

Form D private placements
▶$19.5MraisedJun 2026 · 35 investors · Biotechnology
Rule 506(b)
Rejuvenate Bio has filed a notice of an exempt offering of securities to raise $27,049,354.00 in New Funding. - intelligence360intelligence360.news · Jul 2026Rejuvenate Bio’s Breakthrough: Extending Healthy Lives for Pets and Humanssuperpowers4good.com · Jul 2026
Officers, directors & promoters on the filing
  • Noah DavidsohnExecutive Officer, Director
  • David ZhuDirector
  • Daniel OliverExecutive Officer, Director
Offering amount
$27M
Amount sold
$19.5M
Minimum investment
$20K
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.6MraisedApr 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel OliverExecutive Officer, Director
  • Noah DavidsohnExecutive Officer, Director
Offering amount
$15.3M
Amount sold
$14.6M
Minimum investment
$10K
First sale
Apr 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news